Cancer Clinical Trial Participation 1 Year After the Start of the COVID-19 Pandemic
This cohort study examines the experience of cancer clinical trial enrollment 1 year after the COVID-19 outbreak.
Related Articles
Access to Mental Health and Substance Use Treatment in Comprehensive Primary Care Plus
This cohort study examines whether participation in the Centers for Medicare & Medicaid Services’ Comprehensive Primary Care Plus model was associated with improved access to…
Surrogate Markers and Clinical Outcomes for Nononcologic Chronic Disease Treatments
This study examines the strength of association between surrogate markers used as primary end points in clinical trials to support FDA approval of drugs treating…
Excess Child Mortality Associated With Colombia’s Armed Conflict
This ecological cohort study estimates the proportion of infant and child mortality associated with armed conflict exposure from 1998 to 2019 in Colombia.
Prevalence of Iron Deficiency and Iron-Deficiency Anemia in US Females Aged 12-21 Years, 2003-2020
This study examines prevalence of iron deficiency among females aged 12 to 21 years to inform future screening strategies for iron deficiency and iron-deficiency anemia.
Screening Strategies to Reduce COVID-19 Mortality in Nursing Homes
This cost-effectiveness analysis examines screening strategies and their predicted association with reducing COVID-19 mortality in nursing homes.
Digital Health Interventions and Patient Safety in Abdominal Surgery
This systematic review and meta-analysis evaluates the complication, emergency department, and hospital readmission rates associated with telemedicine vs conventional care in patients who underwent abdominal…
Patients with Long COVID May Tolerate Cautious Exercise Rehabilitation
This Medical News story discusses a clinical trial that tested symptom-guided exercise for patients with long COVID and postexertional malaise.
Introducing JAMA Data Brief
How people consume information is evolving. So is JAMA Medical News. This issue debuts JAMA Data Brief, a new department in the journal’s long-standing Medical…
Poll: Patients Still Trust Their Physicians the Most
This Medical News article discusses a KFF poll about the public’s exposure to and beliefs about inaccurate health information, as well as media use and…
Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia
This randomized clinical trial assesses the safety and effectiveness of plozasiran, an investigational APOC3-targeted drug, in the reduction of serum triglyceride level in patients with…
